CEACAM5 and non-small cell lung carcinoma: The downregulation of plasma miR-204 is also associated with NSCLC patients, with accuracy higher than commonly used CEA and CA19-9 markers (AUC of 0.81, 0.72, and 0.69, respectively), and is correlated with tumor stage, distant metastasis, and shorter survival [62].